These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1862298)

  • 1. Basic studies on ursodeoxycholyl-para-aminobenzoic acid for evaluation of intestinal microflora.
    Takahashi M; Maeda Y; Tashiro H; Akazawa F; Okajima M; Yoshioka S; Matsugu Y; Toyota K; Masaoka Y
    Scand J Gastroenterol; 1991 Jun; 26(6):577-88. PubMed ID: 1862298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new simple test for evaluation of intestinal bacteria.
    Takahashi M; Maeda Y; Tashiro H; Eto T; Goto T; Sanada O
    World J Surg; 1990; 14(5):628-34; discussion 635. PubMed ID: 2238664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.
    Takahashi M; Konishi T; Maeda Y; Matsugu Y; Akazawa F; Eto T; Okajima M; Uchida K; Masaoka Y; Okada K
    Gut; 1993 Jun; 34(6):823-8. PubMed ID: 8314517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rapid evaluation of intestinal bacterial growth using a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
    Maeda Y; Takahashi M; Tashiro H; Akazawa F
    J Pharmacobiodyn; 1989 May; 12(5):272-80. PubMed ID: 2810016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basic studies on the utility of ursodeoxycholic acid derivatives for clinical medicine].
    Konishi T
    Yakugaku Zasshi; 2000 Jan; 120(1):1-15. PubMed ID: 10655778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis and absorption of a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
    Maeda Y; Takahashi M
    J Pharmacobiodyn; 1989 Dec; 12(12):744-53. PubMed ID: 2635732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic studies on 5-(7-hydroxy-3-O-phosphonocholyl)aminosalicylic acid for the evaluation of microbial overgrowth.
    Konishi T; Takahashi M; Ohta S
    Biol Pharm Bull; 1997 Apr; 20(4):370-5. PubMed ID: 9145212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly synthesized compound, PABA-ursodeoxycholic acid, for evaluation of intestinal bacteria.
    Takahashi M; Maeda Y; Matsuno K; Tamura H; Furuyashiki S; Harada M
    Hiroshima J Med Sci; 1987 Dec; 36(4):377-81. PubMed ID: 3502343
    [No Abstract]   [Full Text] [Related]  

  • 9. The ursodeoxycholic acid-p-aminobenzoic acid deconjugation test, a new tool for the diagnosis of bacterial overgrowth syndrome.
    Kiss ZF; Wölfling J; Csáti S; Nagy F; Wittmann T; Schneider G; Lonovics J
    Eur J Gastroenterol Hepatol; 1997 Jul; 9(7):679-82. PubMed ID: 9262976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The ursodeoxycholic acid-p-aminobenzoic acid test in the diagnosis of small bowel bacterial overgrowth syndrome].
    Kiss Z; Wölfling J; Csáti S; Nagy F; Lonovics J; Schneider G
    Orv Hetil; 1997 May; 138(20):1255-8. PubMed ID: 9244859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpancreatic hydrolysis of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (PABA peptide) in the rat small intestine.
    Sterchi EE; Green JR; Lentze MJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):539-47. PubMed ID: 6352892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Studies in cystic fibrosis and Shwachman's syndrome.
    Weizman Z; Forstner GG; Gaskin KJ; Kopelman H; Wong S; Durie PR
    Gastroenterology; 1985 Sep; 89(3):596-604. PubMed ID: 3874804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary p-aminobenzoic acid determined in the pancreatic function test by liquid chromatography, with electrochemical detection.
    Ito S; Maruta K; Imai Y; Kato T; Ito M; Nakajima S; Fujita K; Kurahashi T
    Clin Chem; 1982 Feb; 28(2):323-6. PubMed ID: 6976857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug elimination function of rat small intestine: metabolism and intraluminal excretion.
    Yasuhara M; Kurosaki Y; Kimura T; Sezaki H
    Biochem Pharmacol; 1984 Oct; 33(20):3131-6. PubMed ID: 6333241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorimetric plasma assay for the bentiromide test (BT-PABA) for exocrine pancreatic insufficiency.
    Gharbo SA; Boyer JA; Williamson MJ
    Anal Biochem; 1985 Jul; 148(1):228-32. PubMed ID: 3876041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth.
    Maeda Y; Murakami T
    Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary choloyl-PABA excretion in diagnosing small intestinal bacterial overgrowth: evaluation of a new noninvasive method.
    Bardhan PK; Feger A; Kogon M; Muller J; Gillessen D; Beglinger C; Gyr N
    Dig Dis Sci; 2000 Mar; 45(3):474-9. PubMed ID: 10749320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of serum PABA as a pancreatic function test.
    Lang C; Gyr K; Tonko I; Conen D; Stalder GA
    Gut; 1984 May; 25(5):508-12. PubMed ID: 6609103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and simultaneous high-performance liquid chromatographic assay for the determination of p-aminobenzoic acid and its conjugates in human urine.
    Chan K; Miners JO; Birkett DJ
    J Chromatogr; 1988 Apr; 426(1):103-9. PubMed ID: 3260239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid.
    Nousia-Arvanitakis S; Arvanitakis C; Desai N; Greenberger NJ
    J Pediatr; 1978 May; 92(5):734-7. PubMed ID: 305953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.